logo
IDYA_logo
Dr. Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics (a subsidiary of Samumed) as Chief Medical Officer and Head of Research and Development in Oncology

IDEAYA Biosciences Appoints Darrin M. Beaupre, M.D., Ph.D., as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that Darrin M. Beaupre, M.D., Ph.D., has joined the company as its Chief Medical Officer, effective November 21, 2022

By AP News
Published - Nov 28, 2022, 06:15 AM ET
Last Updated - Mar 28, 2024, 02:58 PM EDT
  • Former Senior Vice President and Head of Early Oncology Development and Clinical Research at Pfizer will lead IDEAYA's clinical development efforts as Chief Medical Officer
  • Over twenty-five years of experience in clinical development and translational research, including at leading pharmaceutical companies and major research institutions
    • Article Source
    Quick Links
    Categories
    Our Offices
    • 10kInfo, Inc.
      13555 SE 36th St
      Bellevue, WA 98006
    • 10kInfo Data Solutions, Pvt Ltd.
      Claywork Create
      11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
      Bengaluru, Karnataka 560076
    4.2 12182024